Tin tức & Cập nhật

Combination therapy with FOLFIRI-ramucirumab exhibits survival advantage similar to ramucirumab plus paclitaxel in patients with advanced upper gastrointestinal (UGI) cancers, reveals a study. However, FOLFIRI-ramucirumab is associated with a longer real-world time to treatment discontinuation (rwTTD).

Patients with HR+/HER2‒ breast cancer treated with immunotherapy show modest improvements in complete response rates, reports a study.

In breast cancer patients with obesity or type 2 diabetes (T2D), the use of a glucagon-like peptide-1 receptor agonist (GLP-1 RA) appears to exert favourable effects on mortality and recurrence, according to a retrospective study.

Patients undergoing cancer surgery who experience unintentional medication discrepancies are susceptible to postoperative adverse drug events (ADEs), reports a study.

Implementing a gradual, catch-up HPV vaccination program can yield considerable long-term public health benefits by reducing the future burden of both cervical and oropharyngeal cancers in Singapore, according to local research.

A randomized, double-blind, placebo-controlled study from Thailand reports a significant reduction in the incidence of chemotherapy-induced peripheral neuropathy (CIPN) among patients with gynaecological cancers treated with neurotoxic chemotherapy who received vitamin B12 supplementation vs placebo.

Sigmoidoscopy screening has reduced the colorectal cancer (CRC) incidence and death, and these benefits tend to be more pronounced in men than in women, according to a Norway study.

In men with hypogonadism who have undergone radical prostatectomy for low-grade prostate cancer, testosterone replacement therapy (TRT) helps improve sexual and physical function, according to the SPIRIT study.